CAS 83799-24-0
:Fexofenadin
- 2-(4-[1-Hydroxy-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butyl]-phenyl)-2-methyl-propionic acid
- 2-(4-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]phenyl)-2-methylpropanoic acid
- 2-[4-(1-Hydroxy-4-{4-[Hydroxy(Diphenyl)Methyl]Piperidin-1-Yl}Butyl)Phenyl]-2-Methylpropanoic Acid
- 4-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethylbenzeneacetic acid
- 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetic acid
- Benzeneacetic acid, 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-
- Carboxyterfenadine
- Fexet
- Mdl 16455
- Telfast 120
- Terfenadine acid metabolite
- Terfenadine carboxylate
- Weitere Synonyme anzeigen
2-(4-{1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid
CAS:Formel:C32H39NO4Reinheit:95%Farbe und Form:SolidMolekulargewicht:501.6564Fexofenadine
CAS:Formel:C32H39NO4Reinheit:≥ 98.0%Farbe und Form:White to beige powderMolekulargewicht:501.66Fexofenadine Hydrochloride
CAS:Formel:C32H39NO4·HClReinheit:>98.0%(T)(HPLC)Farbe und Form:White to Almost white powder to crystalMolekulargewicht:538.13Fexofenadine
CAS:Fexofenadine, a non-sedating antihistamine, treats allergies like hay fever and urticaria.Formel:C32H39NO4Reinheit:99.35%Farbe und Form:White To Off-White SolidMolekulargewicht:501.66Fexofenadine
CAS:Kontrolliertes ProduktApplications The active metabolite of Terfenadine (T114500), a H1-histamine receptor antagonist.
References Garteiz, D.A., et al.: Arzneim.-Forsch., 32, 1185 (1982), Rampe, D., et al.: Mol. Pharmacol., 44, 1240 (1993), Obradovic, T., et al.: Pharm. Res., 24, 318 (2007),Formel:C32H39NO4Farbe und Form:Off-WhiteMolekulargewicht:501.66Fexofenadine
CAS:Fexofenadine is a selective histamine H1 receptor antagonist that has been shown to be effective in the treatment of allergic rhinitis. It is well tolerated and does not have any significant drug interactions. Fexofenadine is metabolized by cytochrome P450 (CYP) enzymes and undergoes extensive first-pass metabolism. This means that it should not interact with CYP inhibitors such as ketoconazole or cimetidine, but may increase the effects of CYP inducers such as phenobarbital or rifampin. Fexofenadine has been shown to inhibit the activity of human multidrug resistance protein 1 (MDR1) and P-glycoprotein (P-gp).
Reinheit:Min. 95 Area-%Farbe und Form:White Off-White PowderMolekulargewicht:501.66 g/mol






